Bacterial profile in human atherosclerotic plaques

References

1. • Moran A.E.
   • et al.
   Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study.
   Circulation. 2014; 129: 1483-1492
   View in Article

   • Google Scholar
2. • Epstein S.E.
   • et al.
   Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry.
   Arterioscler. Thromb. Vasc. Biol. 2000; 20: 1417-1420
   View in Article

   • Google Scholar
3. • Libby P.
   • Egan D.
   • Skarlatos S.
   Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research.
   Circulation. 1997; 96: 4095-4103
   View in Article

   • Google Scholar
4. • Rosenfeld M.E.
   • Campbell L.A.
   Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis.
   Thromb. Haemost. 2011; 106: 858-867
   View in Article

   • Google Scholar
5. • Ott S.J.
   • et al.
   Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease.
   Circulation. 2006; 113: 929-937
   View in Article

   • Google Scholar
6. • Ziganshina E.E.
   • et al.
   Bacterial communities associated with atherosclerotic plaques from Russian individuals with atherosclerosis.
   PLoS One. 2016; 11: e0164836
   View in Article

   • Google Scholar
7. • Calandrini C.A.
   • et al.
   Microbial composition of atherosclerotic plaques.
   Oral Dis. 2014; 20: e128-e134
   View in Article

   • Google Scholar
8. • Koren O.
   • et al.
   Human oral, gut, and plaque microbiota in patients with atherosclerosis.
   Proc. Natl. Acad. Sci. U. S. A. 2011; 108: 4592-4598
   View in Article

   • Google Scholar
9. • Amar J.
   • et al.
   Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept.
   Diabetologia. 2011; 54: 3055-3061
   View in Article

   • Google Scholar
10. • Amar J.
    • et al.
    Blood microbiota dysbiosis is associated with the onset of cardiovascular events in a large general population: the D.E.S.I.R. study.
    PLoS One. 2013; 8: e54461
    View in Article

    • Google Scholar
11. • Backhed F.
    • et al.
    The gut microbiota as an environmental factor that regulates fat storage.
    Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 15718-15723
    View in Article

    • Google Scholar
12. • Turnbaugh P.J.
    • et al.
    A core gut microbiome in obese and lean twins.
    Nature. 2009; 457: 480-484
    View in Article

    • Google Scholar
13. • Wellen K.E.
    • Hotamisligil G.S.
    Inflammation, stress, and diabetes.
    J. Clin. Invest. 2005; 115: 1111-1119
    View in Article

    • Google Scholar
14. • Karlsson F.H.
    • et al.
    Gut metagenome in European women with normal, impaired and diabetic glucose control.
    Nature. 2013; 498: 99-103
    View in Article

    • Google Scholar
15. • Yusuf S.
    • et al.
    Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization.
    Circulation. 2001; 104: 2746-2753
    View in Article

    • Google Scholar
16. • Hansson G.K.
    Inflammation, atherosclerosis, and coronary artery disease.
    N. Engl. J. Med. 2005; 352: 1685-1695
    View in Article

    • Google Scholar
17. • Yilmaz A.
    • et al.
    Accumulation of immune cells and high expression of chemokines/chemokine receptors in the upstream shoulder of atherosclerotic carotid plaques.
    Exp. Mol. Pathol. 2007; 82: 245-255
    View in Article

    • Google Scholar
18. • Fagerberg B.
    • et al.
    Differences in lesion severity and cellular composition between in vivo assessed upstream and downstream sides of human symptomatic carotid atherosclerotic plaques.
    J. Vasc. Res. 2010; 47: 221-230
    View in Article

    • Google Scholar
19. • Salonen A.
    • et al.
    Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: effective recovery of bacterial and archaeal DNA using mechanical cell lysis.
    J. Microbiol. Methods. 2010; 81: 127-134
    View in Article

    • Google Scholar
20. • Suzuki M.T.
    • Taylor L.T.
    • DeLong E.F.
    Quantitative analysis of small-subunit rRNA genes in mixed microbial populations via 5'-nuclease assays.
    Appl. Environ. Microbiol. 2000; 66: 4605-4614
    View in Article

    • Google Scholar
21. • Fierer N.
    • et al.
    The influence of sex, handedness, and washing on the diversity of hand surface bacteria.
    Proc. Natl. Acad. Sci. U. S. A. 2008; 105: 17994-17999
    View in Article

    • Google Scholar
22. • Caporaso J.G.
    • et al.
    QIIME allows analysis of high-throughput community sequencing data.
    Nat. Methods. 2010; 7: 335-336
    View in Article

    • Google Scholar
23. • Edgar R.C.
    Search and clustering orders of magnitude faster than BLAST.
    Bioinformatics. 2010; 26: 2460-2461
    View in Article

    • Google Scholar
24. • DeSantis T.Z.
    • et al.
    Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB.
    Appl. Environ. Microbiol. 2006; 72: 5069-5072
    View in Article

    • Google Scholar
25. • Wang Q.
    • et al.
    Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy.
    Appl. Environ. Microbiol. 2007; 73: 5261-5267
    View in Article

    • Google Scholar
26. • Caporaso J.G.
    • et al.
    PyNAST: a flexible tool for aligning sequences to a template alignment.
    Bioinformatics. 2010; 26: 266-267
    View in Article

    • Google Scholar
27. • Price M.N.
    • Dehal P.S.
    • Arkin A.P.
    FastTree 2–approximately maximum-likelihood trees for large alignments.
    PLoS One. 2010; 5: e9490
    View in Article

    • Google Scholar
28. • Faith D.P.
    Conservation evaluation and phylogenetic diversity.
    Biol. Conserv. 1992; 61: 1-10
    View in Article

    • Google Scholar
29. • Lozupone C.
    • Knight R.
    UniFrac: a new phylogenetic method for comparing microbial communities.
    Appl. Environ. Microbiol. 2005; 71: 8228-8235
    View in Article

    • Google Scholar
30. • Vazquez-Baeza Y.
    • et al.
    EMPeror: a tool for visualizing high-throughput microbial community data.
    Gigascience. 2013; 2: 16
    View in Article

    • Google Scholar
31. • Haas B.J.
    • et al.
    Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons.
    Genome Res. 2011; 21: 494-504
    View in Article

    • Google Scholar
32. • Olson F.J.
    • et al.
    Consistent differences in protein distribution along the longitudinal axis in symptomatic carotid atherosclerotic plaques.
    Biochem. Biophys. Res. Commun. 2010; 401: 574-580
    View in Article

    • Google Scholar
33. • Mitra S.
    • et al.
    In silico analyses of metagenomes from human atherosclerotic plaque samples.
    Microbiome. 2015; 3: 38
    View in Article

    • Google Scholar
34. • Havlik R.J.
    • et al.
    Unlikely association between clinically apparent herpesvirus infection and coronary incidence at older ages.
    Fram. Heart Study. Arteriosclerosis. 1989; 9: 877-880
    View in Article

    • Google Scholar
35. • Adler S.P.
    • et al.
    Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis.
    J. Infect. Dis. 1998; 177: 209-212
    View in Article

    • Google Scholar
36. • Weiss S.M.
    • et al.
    Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy.
    J. Infect. Dis. 1996; 173: 957-962
    View in Article

    • Google Scholar
37. • O'Connor C.M.
    • et al.
    Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial.
    JAMA. 2003; 290: 1459-1466
    View in Article

    • Google Scholar
38. • Grayston J.T.
    • et al.
    Azithromycin for the secondary prevention of coronary events.
    N. Engl. J. Med. 2005; 352: 1637-1645
    View in Article

    • Google Scholar
39. • Cannon C.P.
    • et al.
    Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome.
    N. Engl. J. Med. 2005; 352: 1646-1654
    View in Article

    • Google Scholar
40. • Jespersen C.M.
    • et al.
    Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial.
    BMJ. 2006; 332: 22-27
    View in Article

    • Google Scholar
41. • Elkind M.S.
    • et al.
    Infectious burden and carotid plaque thickness: the northern Manhattan study.
    Stroke. 2010; 41: e117-e122
    View in Article

    • Google Scholar
42. • Georges J.L.
    • et al.
    Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines.
    Am. J. Cardiol. 2003; 92: 515-521
    View in Article

    • Google Scholar
43. • Zhu J.
    • et al.
    Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels.
    Am. J. Cardiol. 2000; 85: 140-146
    View in Article

    • Google Scholar
44. • Karlsson F.H.
    • et al.
    Symptomatic atherosclerosis is associated with an altered gut metagenome.
    Nat. Commun. 2012; 3: 1245
    View in Article

    • Google Scholar
45. • Winek K.
    • et al.
    Depletion of cultivatable gut microbiota by broad-spectrum antibiotic pretreatment worsens outcome after murine stroke.
    Stroke. 2016; 47: 1354-1363
    View in Article

    • Google Scholar
46. • Benakis C.
    • et al.
    Commensal microbiota affects ischemic stroke outcome by regulating intestinal gammadelta T cells.
    Nat. Med. 2016; 22: 516-523
    View in Article

    • Google Scholar
47. • Olson F.J.
    • et al.
    Increased vascularization of shoulder regions of carotid atherosclerotic plaques from patients with diabetes.
    J. Vasc. Surg. 2011; 54 (e5): 1324-1331
    View in Article

    • Google Scholar